Paul Howard Broomfield, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 E Main St, Ste 21, Bay Shore, NY 11706 Phone: 631-968-8288 Fax: 631-968-8268 |
Frank Joseph Karpowicz, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 E Main St, Ste 21, Bay Shore, NY 11706 Phone: 631-968-8288 Fax: 631-968-8268 |
Aaron Richard Harrison, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 E Main St, Ste 21, Bay Shore, NY 11706 Phone: 631-968-8288 Fax: 631-968-8268 |
Robert Thomas Chatalbash, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 East Main Street, Suite 21, Bay Shore, NY 11706 Phone: 631-968-8288 Fax: 631-968-8268 |
Mary Meena Thomas, DO Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 375 East Main Street, Suite 21, Bay Shore, NY 11706 Phone: 631-968-8288 Fax: 631-968-8268 |
Dr. Michael Robert Delman, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 301 E Main St, Bay Shore, NY 11706 Phone: 631-675-4149 |
Jeffrey Roy Ashkin, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 375 E Main St, Ste 21, Bay Shore, NY 11706 Phone: 631-968-8288 Fax: 631-968-8268 |
News Archive
Experts at LSTM have used a novel modelling approach to project the effects of new diagnostic methods and algorithms for the diagnosis of tuberculosis (TB) recently endorsed by the World Health Organization, looking at the patient, health system and population perspective in Tanzania.
Tick bites are known to spread infections. An infectious condition that can affect the brain has been identified for the first time in the United Kingdom and the disease has been found to spread via tick bites say sources.
Researchers from North Carolina State University have pinpointed a particular neuropeptide associated with transmitting itch signals in mice with atopic dermatitis.
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.
› Verified 2 days ago